Cargando…
The Research Advances of Aptamers in Hematologic Malignancies
SIMPLE SUMMARY: Aptamer is a targeting tool with many unique advantages, therefore many experts screened corresponding aptamers in various hematologic malignancies for diagnosis and targeted treatment. In this review, we try to summarize the research progress of aptamers in the diagnosis and treatme...
Autores principales: | Liao, Yongkang, Xiong, Shijun, Ur Rehman, Zaid, He, Xiaoli, Peng, Hongling, Liu, Jing, Sun, Shuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818631/ https://www.ncbi.nlm.nih.gov/pubmed/36612296 http://dx.doi.org/10.3390/cancers15010300 |
Ejemplares similares
-
Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation
por: He, Xiaoli, et al.
Publicado: (2022) -
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
por: Yang, Shuanghui, et al.
Publicado: (2018) -
Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
por: Zhao, Yan, et al.
Publicado: (2021) -
Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies
por: Wang, Zi, et al.
Publicado: (2021) -
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)